Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8 mL dose.

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

The health secretary is planning to remove members of a panel that recommends vaccines if he sees conflicts of interest.

A CDC vaccine advisory committee meeting scheduled for next week has been postponed. It was the first vaccine meeting since ...

A panel of experts that advises the Centers for Disease Control and Prevention on vaccine policy will not meet as previously ...

A GROUP of physicians has urged President Marcos to approve the “next-generation” dengue vaccine as part of the country’s integrated dengue prevention and control strategy. In an appeal letter read by ...

High uptake of RSVpreF vaccine and nirsevimab was observed, with 64% of pregnant individuals and 70% of infants receiving ...

ImmunityBio (IBRX) is jumping 20% after the drug maker reported that the FDA had approved its use of an “alternative source ...

WASHINGTON – To earn the vote he needed to become the nation's top health official, Robert F. Kennedy Jr. made a special ...

The U.S. Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry. This new ...

The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...

Two years on, Bavarian Nordic’s $380 million vaccine M&A move appears to be paying off. | Valneva may have won the ...